p53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3301-3305

  Brant, Ommo ^a   Hoffmann, Markus ^a   Kanappilly, Anthony ^a   Görögh, Tibor ^a   Gottschlich, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Codon 72; Head and neck cancer; p53; Tumour suppressor gene

Indexed keywords

ALCOHOL; NICOTINE; PROTEIN P53;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SURVIVAL; CODON; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CANCER; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CODON; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 35349009597     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Thomas M, Kalita A, Labrecque S, Pirn D, Banks L and Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100, 1999.
2. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S: Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089, 1993.
3. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S and Saisho H: Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17: 261-264, 1996.
4. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234, 1998.
5. Ara S, Lee PS, Hansen MF and Saya H: Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18: 4961, 1990.
6. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X and Crook T: p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 3: 387-402, 2003.
7. Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, Buhtz P, Giers A, Rohrbeck A, Freigang B and Roessner A: Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 164: 1233-1241, 2004.
8. Hamel N, Black MJ, Ghadirian P and Foulkes WD: No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 82: 757-759, 2000.
9. McWilliams JE, Evans AJ, Beer TM, Andersen PE, Cohen JI, Everts EC and Henner WD: Genetic polymorphisms in head and neck cancer risk. Head Neck 22: 609-617, 2000.
10. Hermanek P, Sobin LH (eds.): UICC: TNM Classification of Malignant Tumors, 4th ed., Berlin, Springer, 1987.
11. Gottschlich S, Maune S, Preugschat J, Hoffmann M, Werner JA, Maass JD, Gorogh T, Heidorn K and Rudert H: p53 analysis of laryngeal cancer in exon 4 to 9. Anticancer Res 20: 2613-2616, 2000.
12. Felley-Bosco E, Weston A, Cawley HM, Bennett WP and Harris CC: Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet 53: 752-759, 1993.
13. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE and Spitz MR: Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16: 2205-2208, 1995.
14. Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF and Harris CC: Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15: 583-587, 1994.
15. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A and Beckman L: Is p53 polymorphism maintained by natural selection? Hum Hered 44: 266-270, 1994.
16. Sjalander A, Birgander R, Saha N, Beckman L and Beckman G: p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 46: 41-48, 1996.
17. Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, Klimek F, Andersson S and Tommasino M: p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 61: 608-611, 2001.
18. Koushik A, Platt RW and Franco EL: p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13: 11-22, 2004.
19. Matakidou A, Eisen T and Houlston RS: TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18: 377-385, 2003.
20. Begg CB and Zhang ZF: Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3: 173-175, 1994.
21. Khoury MJ and Flanders WD: Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 144: 207-213, 1996.
22. Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, Storey A and Matlashewski G: P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 87: 528-533, 2000.
23. Giannoudis A, Graham DA, Southern SA and Herrington CS: p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intraepithelial lesions and invasive squamous carcinoma of the cervix. Int J Cancer 83: 66-69, 1999.
24. Olschwang S, Laurent-Puig P, Vassal A, Salmon RJ and Thomas G: Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population. Hum Genet 86: 369-370, 1991.
25. Maier H, Dietz A, Gewelke U, Heller WD and Weidauer H: Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 70: 320-327, 1992.
26. Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H and Fujisawa T: Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients. Int J Oncol 12: 577-581, 1998.
27. McKaig RG, Baric RS and Olshan AF: Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20: 250-265, 1998.
28. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann AM, McDougall JK and Galloway DA: Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90: 1626-1636, 1998.
29. Portugal LG, Goldenberg JD, Wenig BL, Ferrer KT, Nodzenski E, Sabnani JB, Javier C, Weichselbaum RR and Vokes EE: Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 123: 1230-1234, 1997.